Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026

Core Viewpoint - Eton Pharmaceuticals, Inc. will report its fourth quarter and full year 2025 financial results on March 19, 2026, with a conference call scheduled for 4:30 p.m. ET to discuss the results [1]. Company Overview - Eton Pharmaceuticals is focused on developing and commercializing treatments for rare diseases, currently offering ten commercial products for rare diseases [4]. - The company has four additional product candidates in late-stage development, including Amglidia, ET-700, ET-800, and ZENEO hydrocortisone autoinjector [4].